Registry of people in China with monogenic diabetes, using genetic testing
Collects genetic information from people in China with monogenic diabetes through genetic testing.
Plain-language title generated from the registry record
Registry title: China Monogenic Diabetes Registry
Key facts
- Where
- Tianjin, ChinaSee the site
Where in China
- Tianjin Medical University General HospitalTianjin, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tianjin Medical University General Hospital
- Trial code
- NCT07492004
- Record updated
- 25 March 2026
- Original description
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to:Read full original descriptionShow less
China Monogenic Diabetes Registry
This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to:
Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution
Participants will:
* Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis
Inclusion: Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years of age with ≥1 first-degree relative (parent, sibling, or offspring) diagnosed with diabetes before 40 years of age; Body mass index (BMI) at diagnosis 28 kg/m²; Negative glutamic acid decarboxylase antibody (GAD-Ab).
Exclusion: Secondary diabetes; Active malignancy or history of malignant tumor within the past 5 years.